# Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Study · id `cardio:ct-nct07864168` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07864168](<https://clinicaltrials.gov/study/NCT07864168>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07864168

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1500 participants.

## Technical summary

Registry record NCT07864168. Allocation not applicable; no masking; primary purpose other. Start 2026-10-05 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 1500 participants (planned count; ClinicalTrials.gov record NCT07864168, source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)
- Started: 2026-10-05 (actual) (ClinicalTrials.gov record NCT07864168, source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07864168, source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)
- Completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT07864168, source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07864168, source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07864168-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- Condition: Type 1 Diabetes
- Condition: Type 2 Diabetes
- Intervention (Device): Next Generation Extended Wear Sensors
- Lead sponsor: Medtronic MiniMed, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Medtronic MiniMed, Inc. (`cardio:org-medtronic-minimed-inc`)

## Provenance

Content hash: 2ef41cf6e32c15e8ef0c419b5c33376e16dd9399ca2f169d0ee0579bd8c90900
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
